Eli Lilly (LLY) Financial Analysis & Valuation | Quarter Chart

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... more
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Ba... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$1.12TExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryUSCEODavid A. Ricks
IPO Date1972-06-01CAGR7.77%
Employees50,000Websitewww.lilly.com
Div. Yield0.99%Payout Ratio22.1%
Buy Back Yield0.85%Total Yield1.84%
LLY chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
Enterprise Value$974.56BP/E Ratio40.3
Forward P/E26.41PEG Ratio0.25
P/S Ratio10.07P/B Ratio22.19
P/CF Ratio33.79P/FCF Ratio53.66
EPS$29.42EPS Growth 1Y129.05%
EPS Growth 3Y359.97%EPS Growth 5Y342.61%
Revenue Growth 1Y47.44%Gross Margin0.84%
Operating Margin0.46%Profit Margin0.35%
ROE1.01%ROA0.22%
ROCE0.41%Current Ratio1.5
Quick Ratio1.1Cash Ratio0.14
Debt/Equity1.39Interest Coverage37.5
Altman Z Score9.9Piotroski Score6

View Eli Lilly financial charts →

Eli Lilly (LLY) valuation & financials

Eli Lilly (LLY) has a market capitalization of $1.12T and trades at a price-to-earnings ratio of 40.3. It operates in the Healthcare sector (Drug Manufacturers - General).

Eli Lilly's revenue grew +47.4% over the last year.

Eli Lilly's next earnings report is scheduled for August 5, 2026 before market open; analysts estimate EPS of $7.47.

📈 Analysts estimate LLY EPS of $7.47 for the upcoming quarter. See Eli Lilly revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Eli Lilly (LLY) — frequently asked questions

When does Eli Lilly (LLY) report earnings next?

Eli Lilly is expected to report earnings on August 5, 2026 before market open. Analysts estimate EPS of $7.47.

What is Eli Lilly's market cap?

Eli Lilly (LLY) has a market capitalization of $1.12T.

What is LLY's P/E ratio?

Eli Lilly trades at a price-to-earnings ratio of 40.3, with trailing twelve-month EPS of $29.42.

How fast is Eli Lilly growing?

Eli Lilly's revenue grew +47.4% over the last year.

Compare with other Healthcare companies: Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW) · Novartis (NVS)

Eli Lilly revenue & earnings charts →